Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials.
about
Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary diseasePrevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.Stable chronic obstructive pulmonary disease.Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease.Early detection and management of COPD. What you can do to reduce the impact of this disabling disease.Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trialsProfile of aclidinium bromide in the treatment of chronic obstructive pulmonary diseaseLack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway diseaseA randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study GroupMeta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.Chronic obstructive pulmonary disease: role of matrix metalloproteases and future challenges of drug therapy.Inhaled anticholinergic use and all-cause mortality among elderly Medicare beneficiaries with chronic obstructive pulmonary disease.Bronchodilators in COPD: impact of beta-agonists and anticholinergics on severe exacerbations and mortality.The development of anticholinergics in the management of COPD.Treating patients with respiratory disease who smoke.Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?Aclidinium bromide: an alternative long-acting inhaled anticholinergic in the management of chronic obstructive pulmonary disease.Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airwaysUse of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease.Single dose of inhaled procaterol has a prolonged effect on exercise performance of patients with COPD.Can 'old' lungs be restored? Strategies for preserving lung health and preventing and treating COPD.Airflow Limitation is Underrecognized in Well-Functioning Older People
P2860
Q24250271-3612DF9E-D4D3-49C7-B772-659F4527858FQ27348844-B8A81A32-7633-4B9A-9261-4BC41244915DQ33716242-07B9D563-0CFE-47BF-A14A-8FB4835799ABQ33932911-2B04615C-85BF-4D13-B074-D0767C7715A2Q34705576-159CA1B0-6D2A-4246-92A4-F25DFC8FE1BDQ35153689-7FA3BACB-3DAF-4DA6-9C98-6E6E4088C3EBQ35268320-0E0D5264-8167-43D7-B95B-471DBCDEC706Q35533694-275680A1-7C2E-4491-A7BE-57621CAA3319Q35533708-2F3944F7-F4CB-4439-940F-CA8D926472E6Q35696088-5CEFA656-93CB-49B7-A219-649E25CC9F77Q36861614-C7242FA8-E351-4B27-86A3-E89D29AD2809Q36929739-6BA446AA-A0CB-423E-8C0E-50BF302BB10AQ37017238-F7CA9D7F-2759-4970-B568-647F117D1C86Q37017248-156F1D21-E5FF-42E5-9EC4-8C0FF598BD94Q37362600-538F57D7-B11A-46DC-8192-6B7EBB1042B1Q37895710-C8AEC659-8A0C-4BF1-98F8-35F3B8FA554FQ38112092-D79FA594-D170-4595-B407-26DAE2D038A1Q41869781-2B32E1ED-8ACF-4396-8930-54767A33499CQ43584756-C47F38B0-15B7-4489-9D68-F5D173EFBA1CQ43732336-D9090E07-EBD1-4787-8014-8FEA5C87D97FQ46522568-4E6315AC-0B81-41D5-BCC9-BF609FD3CA36Q48711536-6092853E-52AF-4FD2-96C1-247E04E50307Q57392464-42DA6920-D3D9-42D6-B1B9-14877C1D7A07
P2860
Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Extended therapy with ipratrop ...... ta from seven clinical trials.
@ast
Extended therapy with ipratrop ...... ta from seven clinical trials.
@en
type
label
Extended therapy with ipratrop ...... ta from seven clinical trials.
@ast
Extended therapy with ipratrop ...... ta from seven clinical trials.
@en
prefLabel
Extended therapy with ipratrop ...... ta from seven clinical trials.
@ast
Extended therapy with ipratrop ...... ta from seven clinical trials.
@en
P2093
P356
P1433
P1476
Extended therapy with ipratrop ...... ta from seven clinical trials.
@en
P2093
P356
10.1378/CHEST.110.1.62
P407
P577
1996-07-01T00:00:00Z